Assessment of Post-Vaccination Adverse Effects in Medical Students following COVID-19 Immunization in Peshawar
Keywords:
COVID-19 vaccination, Adverse Effects, Medical StudentsAbstract
Background: As COVID-19 vaccinations became widely distributed, assessing their safety profile, especially among specific populations, has become crucial. Sinopharm, a prominent COVID-19 vaccine, has been administered extensively; however, data on its adverse effects in specific groups such as undergraduate Medical students remains limited. Objective: To assess the adverse effects following COVID-19 vaccination with Sinopharm among undergraduate medica (MBBS) students at a tertiary care institution, providing insights into the vaccine’s safety within this demographic. Methodology: A cross-sectional study was conducted among MBBS students at a tertiary care institution who received the Sinopharm vaccine at tertiary care institutions from January 2022 to June 2022. 200 MBBS students participanted in this study, and they were surveyed for adverse effects through a structured questionnaire administered immediately post-vaccination and during follow-up visits. Adverse effects were categorized into local and systemic reactions. Data analysis involved descriptive statistics to determine the frequency and severity of reported adverse effects. Results: Among study cases, the most commonly reported adverse effects included pain at the injection site (68%), redness (25%), and swelling (15%). Systemic reactions included fever (45%), headache (40%), and fatigue (50%). Severe adverse effects were rare, with only 5% reporting significant reactions such as allergic reactions or persistent high fever. Most adverse effects were mild to moderate and resolved within a few days. Conclusion: The study reveals that Sinopharm COVID-19 vaccination is generally well-tolerated among MBBS students, with the majority experiencing mild to moderate adverse effects. The findings align with existing literature on vaccine safety and provide reassurance regarding the vaccine's use in this population. Ongoing monitoring and reporting of adverse effects are essential to ensure continued safety and efficacy of COVID-19 vaccines. . Thus, it was concluded that vaccine have no serious side effects.References
Acter T, Uddin N, Das J, Akhter A, Choudhury TR, Kim S. Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency. Sci Total Environ. 2020;730:138996. DOI:10.1016/j.scitotenv.2020.138996.
Malik NS, Umair M, Qasim F, Azam A, Muddassar M, Qasim R. Does the COVID vaccine really help? A cross-sectional study to assess the positivity rate among Health Care Workers and staff members at Tertiary Care Hospitals. Pak J Chest Med. 2023;29(3):254-61.
Bauchner H, Sharfstein J. A bold response to the COVID-19 pandemic: medical students, national service, and public health. JAMA. 2020;323(18):1790-1. DOI:10.1001/jama.2020.5109.
Ganesan S, Al Ketbi LM, Al Kaabi N, Al Mansoori M, Al Maskari NN, Al Shamsi MS, et al. Vaccine side effects following COVID-19 vaccination among the residents of the UAE—an observational study. Front Public Health. 2022;10:876336. DOI:10.3389/fpubh.2022.876336.
Rabail R, Ahmed W, Ilyas M, Rajoka MS, Hassoun A, Khalid AR, et al. The side effects and adverse clinical cases reported after COVID-19 immunization. Vaccines. 2022;10(4):488. DOI:10.3390/vaccines10040488.
Menni C, Klaser K, May A, Polidori L, Capdevila J, Louca P, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis. 2021;21(7):939-49. DOI:10.1016/S1473-3099(21)00149-1.
Andrzejczak-Grz?dko S, Czudy Z, Donderska M. Side effects after COVID-19 vaccinations among residents of Poland. Eur Rev Med Pharmacol Sci. 2021;25(12):4418-21. DOI:10.26355/eurrev_202106_25771.
Greenhawt M, Abrams EM, Shaker M, Chu DK, Khan D, Akin C, et al. The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and international consensus approach. J Allergy Clin Immunol Pract. 2021;9(10):3546-67. DOI:10.1016/j.jaip.2021.06.029.
Cuschieri S, Borg M, Agius S, Souness J, Brincat A, Grech V. Adverse reactions to Pfizer?BioNTech vaccination of healthcare workers at Malta's state hospital. Int J Clin Pract. 2021;75(10):e14219. DOI:10.1111/ijcp.14219.
Kramer V, Papazova I, Thoma A, Kunz M, Falkai P, Schneider-Axmann T, et al. Subjective burden and perspectives of German healthcare workers during the COVID-19 pandemic. Eur Arch Psychiatry Clin Neurosci. 2021;271:271-81. DOI:10.1007/s00406-020-01220-w.
Tani N, Ikematsu H, Goto T, Gondo K, Inoue T, Yanagihara Y, et al. Correlation of postvaccination fever with specific antibody response to severe acute respiratory syndrome coronavirus 2 BNT162b2 booster and no significant influence of antipyretic medication. Open Forum Infect Dis. 2022;9(10):ofac472. DOI:10.1093/ofid/ofac472.
Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020;15(11):e0240784. DOI:10.1371/journal.pone.0240784.
Chakraborty C, Sharma AR, Bhattacharya M, Agoramoorthy G, Lee SS. The drug repurposing for COVID-19 clinical trials provide very effective therapeutic combinations: lessons learned from major clinical studies. Front Pharmacol. 2021;12:704205. DOI:10.3389/fphar.2021.704205.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Chest Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
